More on ALVO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (2.5 Score)

Upcoming Events

- Earnings (5/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Alvotech (NQ:ALVO)
Delayed: 4.01 -0.15 (3.61%)
Prev. Close $4.16  
Open$4.10 
52 Wk High$ 
52 Wk Low$ 
Day High$4.11 
Day Low$3.99 
P/E N/A  
EPS$ 
Volume311,842 

Friends, Peers and Foes (?): ALVO SDB, TEVA, NBI, AMRX, RDY (more...)

Mar 4, 2026 03:00 AM Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
Feb 27, 2026 07:12 AM Form 6-K Alvotech For: Feb 27
Feb 11, 2026 11:00 AM Alvotech issues 12.5 million shares to subsidiary for $65 million
Feb 11, 2026 11:00 AM Alvotech Announces Increase in Number of Own Shares
Feb 5, 2026 07:00 AM Form 6-K Alvotech For: Feb 05
Feb 5, 2026 05:48 AM Alvotech reports positive results for Entyvio biosimilar study
Feb 5, 2026 03:00 AM Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
Feb 2, 2026 07:00 AM Form 6-K Alvotech For: Feb 02
Feb 2, 2026 04:42 AM Alvotech signs biosimilar supply deals with Sandoz for Canada, Australia
Feb 2, 2026 03:00 AM Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
View All Articles

Entities mentioned with ALVO

View All Entities